Drugs

Rationale for the Use of Aldosterone Antagonists in Congestive Heart Failure
pp. 723-731(9)
Authors: Rocha R.; Williams G.H.

New Prospects for the Treatment of Lysosomal Storage Diseases
pp. 733-742(10)
Authors: Schiffmann R.; Brady R.O.

Substance Misuse in Patients with Schizophrenia: Epidemiology and Management
pp. 743-755(13)
Authors: Kavanagh D.J.; McGrath J.; Saunders J.B.; Dore G.; Clark D.

Fetal Pharmacotherapy
pp. 757-773(17)
Authors: Koren G.; Klinger G.; Ohlsson A.

Emerging Therapies in the Pharmacological Treatment of Parkinson’s Disease
pp. 775-786(12)
Authors: Korczyn A.D.; Nussbaum M.

Candesartan Cilexetil plus Hydrochlorothiazide Combination: A Review of its Use in Hypertension
pp. 787-816(30)
Authors: Melian E.B.; Jarvis B.

Topical Pimecrolimus: A Review of its Clinical Potential in the Management of Atopic Dermatitis
pp. 817-840(24)
Authors: Wellington K.; Jarvis B.

Bivalirudin: A Review of its Potential Place in the Management of Acute Coronary Syndromes
pp. 841-870(30)
Authors: Carswell C.I.; Plosker G.L.